You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BNP level > 100 ng / l or NT-proBNP > 300 ng /l

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biomarkers in Patients With Suspected HFpEF

Not yet recruiting
  • Heart Failure
  • +2 more
  • Plasma biomarker levels
  • Glasgow, United Kingdom
  • +2 more
Oct 20, 2023

B-type Natriuretic Peptide With N-terminal Pro B-type

Recruiting
  • Perioperative Care
  • NT ProBNP (Roche)
  • Kingston, Ontario, Canada
    Kingston Health Sciences Centre
Jun 29, 2022

Pulmonary Arterial Hypertension Participants Treated With

Recruiting
  • Pulmonary Arterial Hypertension
  • PAH medication
  • Acquaviva Delle Fonti, Italy
  • +34 more
Feb 1, 2023

Correlation Between Preoperative NT-proBNP and Postoperative AKI

Recruiting
  • Acute Kidney Injury
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Nov 22, 2023

    Fluid Overload, Dialysis; Complications Trial in Umea (Ultrafiltration rate)

    Recruiting
    • Fluid Overload
    • Dialysis; Complications
    • Ultrafiltration rate
    • Umea, Sweden
      Region Vasterbotten, Norrlands Universitetssjukhus, Dialysen
    Nov 22, 2023

    Myocardial Injury After Non-cardiac Surgery, Abdomen, Acute Trial in Hillerød (Troponin I)

    Completed
    • Myocardial Injury After Non-cardiac Surgery
    • Abdomen, Acute
    • Troponin I
    • Hillerød, Denmark
      Copenhagen University Hospital - North Zealand
    Jul 2, 2023

    Cardiovascular Risk Factor Trial in Vienna (Levosimendan, Placebo)

    Recruiting
    • Cardiovascular Risk Factor
    • Vienna, Austria
      Medical University of Vienna
    Aug 16, 2022

    Diabetes, Type 2 Trial in Tanta (Dapagliflozin 5Mg Tab, Glimepiride 4Mg Tab)

    Completed
    • Diabetes Mellitus, Type 2
    • Dapagliflozin 5Mg Tab
    • Glimepiride 4Mg Tab
    • Tanta, El-Gharbia, Egypt
      Tanta University Hospital
    Aug 11, 2022

    Benign Paroxysmal Positional Vertigo, Vitamin D, Antioxidants Trial in Roma (Vertistop® D)

    Completed
    • Benign Paroxysmal Positional Vertigo
    • +2 more
    • Vertistop® D
    • Roma, Italy
      Clinica Otorinolaringoiatrica
    Feb 24, 2023

    Tooth Loss, Vitamin D3 Deficiency, Osteomalacia Trial in Moscow (Dental implantation)

    Completed
    • Tooth Loss
    • +2 more
    • Dental implantation
    • Moscow, Russian Federation
    • +1 more
    Aug 10, 2022

    Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

    Withdrawn
    • Amyloidosis
    • Light Chain (AL) Amyloidosis
    • (no location specified)
    Dec 29, 2022

    Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction Trial in Ostrava (Nebivolol, Valsartan and Sacubitril,

    Not yet recruiting
    • Cardiovascular Diseases
    • Heart Failure With Reduced Ejection Fraction
    • Ostrava, Czech Republic, Czechia
      University Hospital Ostrava
    Sep 6, 2023

    Heart Failure Trial in Armenia, Bosnia and Herzegovina, Russian Federation (Ringer's (8.6 g/L sodium chloride, 0.33 g/L calcium

    Completed
    • Heart Failure
    • Ringer's (8.6 g/L sodium chloride, 0.33 g/L calcium chloride, 0.3 g/L potassium chloride) Solution
    • Intravenous Bolus Furosemide
    • Yerevan, Armenia
    • +12 more
    Apr 11, 2022

    Type 1 Diabetes Trial (Empagliflozin, Placebo)

    Not yet recruiting
    • Type 1 Diabetes
    • (no location specified)
    Aug 31, 2023

    Cardiac Amyloidosis in Spinal Stenosis: the CASS-study

    Recruiting
    • Cardiac Amyloidosis
      • Brugge, Belgium
        AZ Sint-Jan Brugge-Oostende AV
      Jul 22, 2021

      1 asPotential Biomarker for Colorectal Cancer Diagnosis and

      Not yet recruiting
      • Colorectal Cancer
      • Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
      • (no location specified)
      Mar 20, 2023

      Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg

      Active, not recruiting
      Has Results
      • Metastatic Triple Negative Breast Cancer
      • Olaparib Continuous (28-Day cycle) 300 mg BD.
      • +2 more
      • Birmingham, Alabama
      • +140 more
      Nov 17, 2022

      Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Los Angeles (Non-invasive hemodynamic

      Enrolling by invitation
      • Pulmonary Arterial Hypertension
      • Chronic Thromboembolic Pulmonary Hypertension
      • Non-invasive hemodynamic measurements
      • Los Angeles, California
        Ronald Reagan UCLA Medical Center
      Nov 8, 2022

      Repeatability of NT-proBNP Testing Using Laboratory and Point of

      Active, not recruiting
      • Pulmonary Artery Hypertension
      • Exercise group
      • Sheffield, South Yorkshire, United Kingdom
        Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital
      Jun 14, 2022

      Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction Trial in Worldwide

      Recruiting
      • Heart Failure
      • +4 more
      • Alexander City, Alabama
      • +100 more
      Sep 28, 2022

      The Predictive Value of Progesterone

      Recruiting
      • Progesterone Treshold in Artificial Embryo Transfer Cycles
        • Ghent, Belgium
          Ghent University Hospital - Department of Reproductive Medicine
        May 16, 2023

        Early Management, Acute Heart Failure, NSTEMI - Non-ST Segment Elevation MI Trial in China (Regular management+Levosimendan)

        Enrolling by invitation
        • Early Management
        • +2 more
        • Regular management+Levosimendan
        • Hefei, Anhui, China
        • +13 more
        Jul 15, 2021

        Preoperative BNP: Epidemiological Patterns, Management

        Completed
        • Myocardial Infarction Postoperative
        • +2 more
        • Cardiac risk stratification using preoperative BNP measurement, followed by postoperative cardiac monitoring
        • Use of traditional perioperative cardiac risk stratification only
        • Edmonton, Alberta, Canada
          University of Alberta Hospital Pre-Admission Clinic
        Jul 25, 2022

        Neisseria Gonorrhoeae Infection, Asymptomatic Pharyngeal Carriage Trial (Absence of antibiotic treatment, Ceftriaxone)

        Not yet recruiting
        • Neisseria Gonorrhoeae Infection
        • Asymptomatic Pharyngeal Carriage
        • (no location specified)
        Jul 24, 2023

        Pulmonary Hypertension Trial in Aswan (Treprostinil)

        Recruiting
        • Pulmonary Hypertension
        • Aswan, Egypt
          Aswan Heart Centre - Magdi Yacoub Heart Foundation
        Dec 14, 2022